Dr. Agarwal's Eye [DRAGARWQ] vs Apollo Hospitals [APOLLOHOSP] Detailed Stock Comparison
Dr. Agarwal's Eye
BSE
Loading...
Apollo Hospitals
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dr. Agarwal's Eye wins in 11 metrics, Apollo Hospitals wins in 9 metrics, with 0 ties. Dr. Agarwal's Eye appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr. Agarwal's Eye | Apollo Hospitals | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 40.35 | 68.67 | Dr. Agarwal's Eye |
| Price-to-Book Ratio | 11.14 | 13.06 | Dr. Agarwal's Eye |
| Debt-to-Equity Ratio | 158.94 | 90.89 | Apollo Hospitals |
| PEG Ratio | 1.81 | 1.64 | Apollo Hospitals |
| EV/EBITDA | 20.32 | 38.50 | Dr. Agarwal's Eye |
| Profit Margin (TTM) | 13.96% | 6.98% | Dr. Agarwal's Eye |
| Operating Margin (TTM) | 22.71% | 10.91% | Dr. Agarwal's Eye |
| EBITDA Margin (TTM) | 22.71% | 10.91% | Dr. Agarwal's Eye |
| Return on Equity | 26.07% | 16.71% | Dr. Agarwal's Eye |
| Return on Assets (TTM) | 8.91% | 7.00% | Dr. Agarwal's Eye |
| Free Cash Flow (TTM) | $-83.80M | $4.24B | Apollo Hospitals |
| Dividend Yield | 0.11% | 0.27% | Apollo Hospitals |
| 1-Year Return | 4.92% | 9.98% | Apollo Hospitals |
| Price-to-Sales Ratio (TTM) | 5.64 | 4.76 | Apollo Hospitals |
| Enterprise Value | $26.43B | $1,132.85B | Apollo Hospitals |
| EV/Revenue Ratio | 6.38 | 5.02 | Apollo Hospitals |
| Gross Profit Margin (TTM) | 77.64% | 47.83% | Dr. Agarwal's Eye |
| Revenue per Share (TTM) | $881 | $1,568 | Apollo Hospitals |
| Earnings per Share (Diluted) | $123.07 | $108.64 | Dr. Agarwal's Eye |
| Beta (Stock Volatility) | -0.36 | 0.18 | Dr. Agarwal's Eye |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Dr. Agarwal's Eye vs Apollo Hospitals Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye | -0.31% | 2.98% | 9.84% | 14.47% | 16.54% | -23.53% |
| Apollo Hospitals | 0.11% | -0.81% | -3.70% | -1.53% | 11.66% | 1.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye | 4.92% | 358.10% | 1,895.43% | 3,647.65% | 6,296.19% | 14,656.04% |
| Apollo Hospitals | 9.98% | 69.53% | 227.15% | 412.12% | 1,304.24% | 3,263.21% |
News Based Sentiment: Dr. Agarwal's Eye vs Apollo Hospitals
Dr. Agarwal's Eye
News based Sentiment: POSITIVE
September was a strong month for Dr. Agarwal's, marked by impressive financial results, a commitment to shareholder returns through a 35% dividend, and increasing institutional investor confidence. Long-term projections from Walletinvestor.com further reinforce a positive investment outlook, suggesting significant potential for future growth.
Apollo Hospitals
News based Sentiment: POSITIVE
Apollo Hospitals demonstrated robust financial performance and continued strategic expansion throughout September, highlighted by strong earnings, infrastructure investments, and a focus on specialized care. While insider selling presents a minor concern, the overall narrative is positive, supported by strong growth projections and a favorable long-term outlook.
Performance & Financial Health Analysis: Dr. Agarwal's Eye vs Apollo Hospitals
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹23.46B | ₹1.08T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1,476 | 297,884 |
| 90 Day Avg. Volume | 3,361 | 333,772 |
| Last Close | ₹4,950.65 | ₹7,449.50 |
| 52 Week Range | ₹3,500.00 - ₹7,300.00 | ₹6,001.00 - ₹7,980.00 |
| % from 52W High | -32.18% | -6.65% |
| All-Time High | ₹7,300.00 (Dec 30, 2024) | ₹552,030.00 (Nov 20, 2023) |
| % from All-Time High | -32.18% | -98.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.15% |
| Quarterly Earnings Growth | 0.22% | 0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.07% |
| Operating Margin (TTM) | 0.23% | 0.11% |
| Return on Equity (TTM) | 0.26% | 0.17% |
| Debt to Equity (MRQ) | 158.94 | 90.89 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹445.96 | ₹571.15 |
| Cash per Share (MRQ) | ₹52.76 | ₹139.82 |
| Operating Cash Flow (TTM) | ₹738.70M | ₹14.57B |
| Levered Free Cash Flow (TTM) | ₹546.50M | ₹14.46B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | 0.27% |
| Last 12-Month Dividend | ₹5.00 | ₹19.00 |
Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye vs Apollo Hospitals
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 40.35 | 68.67 |
| Forward P/E | 510.88 | 91.42 |
| PEG Ratio | 1.81 | 1.64 |
| Price to Sales (TTM) | 5.64 | 4.76 |
| Price to Book (MRQ) | 11.14 | 13.06 |
| Market Capitalization | ||
| Market Capitalization | ₹23.46B | ₹1.08T |
| Enterprise Value | ₹26.43B | ₹1.13T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.38 | 5.02 |
| Enterprise to EBITDA | 20.32 | 38.50 |
| Risk & Other Metrics | ||
| Beta | -0.36 | 0.18 |
| Book Value per Share (MRQ) | ₹445.96 | ₹571.15 |
Financial Statements Comparison: Dr. Agarwal's Eye vs Apollo Hospitals
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Revenue/Sales | ₹1.17B | ₹58.42B |
| Cost of Goods Sold | ₹261.40M | ₹30.48B |
| Gross Profit | ₹907.80M | ₹27.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹265.50M | ₹6.37B |
| EBITDA | ₹379.30M | ₹9.06B |
| Pre-Tax Income | ₹231.90M | ₹5.83B |
| Income Tax | ₹59.30M | ₹1.42B |
| Net Income (Profit) | ₹172.60M | ₹4.41B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Cash & Equivalents | ₹111.60M | ₹5.78B |
| Total Current Assets | ₹559.40M | ₹70.29B |
| Total Current Liabilities | ₹869.80M | ₹45.79B |
| Long-Term Debt | ₹3.06B | ₹43.86B |
| Total Shareholders Equity | ₹2.10B | ₹86.53B |
| Retained Earnings | ₹1.99B | ₹39.41B |
| Property, Plant & Equipment | ₹1.37B | ₹39.33B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,476 | 297,884 |
| Average Daily Volume (90 Day) | 3,361 | 333,772 |
| Shares Outstanding | 4.70M | 143.78M |
| Float Shares | 1.11M | 101.35M |
| % Held by Insiders | 0.81% | 0.30% |
| % Held by Institutions | 0.02% | 0.47% |
Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye vs Apollo Hospitals
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Last 12-Month Dividend | ₹5.00 | ₹19.00 |
| Last 12-Month Dividend Yield | 0.11% | 0.27% |
| 3-Year Avg Annual Dividend | ₹4.50 | ₹20.25 |
| 3-Year Avg Dividend Yield | 0.12% | 0.17% |
| 3-Year Total Dividends | ₹13.50 | ₹60.75 |
| Ex-Dividend Date | Nov 08, 2024 | Feb 14, 2025 |